tpan.com: Test Positive Aware Network
Home
 

Positively Aware will treat all communications (letters, faxes, e-mail, etc.) as letters to the editor unless otherwise instructed. We reserve the right to edit for length, style or clarity.

Write to:
 
Positively Aware
5537 N. Broadway St.
Chicago, IL 60640-1405
Fax:   (773) 989-9494
E-mail:   publications@tpan.com


Subjects in this issue:

Drug Guide Clarifications and Corrections

Drug Guide

Updat On My Condition

Saved My Life

Switching Medications

Drug Guide Clarifications and Corrections

The Kaletra dose in the annual drug guide incorrectly stated that a once-daily dose cannot be taken with Lexiva or Viracept and that three tablets twice a day should be taken with those drugs. We apologize for the error.

The Kaletra dose also stated that three tablets twice a day should be taken with Sustiva or Viramune, and by people who are treatment experienced. The statement should say that this dose can be taken under these criteria. An Abbott Laboratories medical liaison, however, tells us that the three tablets twice a day dose “may be considered” for people who are both treatment experienced and taking Sustiva or Viramune.

Back to Top


Drug Guide

On my recent trip to my healthcare provider, I was informed that it is time for me to start my antiviral regimen. How fortunate for me to find your 10th Annual HIV Drug Guide on this day. It has been very helpful so far. I never knew such a publication existed. I plan on being very proactive in my care, and make decisions with my provider that best suit me. I was also glad to see that previous issues have dealt with minority issues as well. Bravo and kudos to TPAN. I was glad when I found out that I could receive a subscription to this wonderful journal. Thank you for your help and advocacy.

Name withheld by request, Detroit.

Back to Top


Update On My Condition

I shall be leaving the bounds of imprisonment shortly. I wrote to TPAN in a letter published in July/August 1997, titled “Spitting Image.” The Commonwealth of Pennsylvania convicted me on the claim that I attempted to infect two police officers through saliva! These same police did not have a policy for handling HIV-positive prisoners, as required under the AIDS amendments of 1988.

My humor and the information I have so consistently received from TPAN (via Positively Aware), along with a very liberal dose of God’s infinite graces, have sustained me for the 10 years of imprisonment I have endured, due largely to my HIV-positive status (I have been positive for nearly 20 years), and I am in better shape, both physically and mentally, than a lot of the “young bucks” coming in.

My CD4 T-cell count is 407, my viral load is 103, and my weight is a solid 150 pounds. I’ve been on a drug regimen of [Videx and Retrovir] plus Sustiva now for eight months, after I had taken a “drug holiday” of two years from the substandard regimen of just [Videx and Retrovir] I was on for eight years. I laugh a lot, and am a voracious reader of HIV/AIDS information and law.

The future is scary sometimes, due to its inherent uncertainty, especially if one has been in a 6 by 12 foot prison cell for the past decade and has had to watch the world evolve through prison bars. I am hopeful that wherever I eventually do decide to call “home” will be a place where I will be intelligently capable of having meaningful dialogue on HIV/AIDS related issues, that advocacy and activism will ensure, and who knows, maybe we can all put our efforts together and find a cure for this hideous disease that has cost so much in terms of suffering and loss.

I sincerely thank you again for providing me with Positively Aware, which, along with other publications, allows me to proclaim that I am a “survivor extraordinaire.”

Mark Tull, Graterford, Pennsylvania

Back to Top

Saved My Life


“Dating and Daring to Love Again” (March/April 2005) really saved my life. I was beginning to sink into the pit of despair after I lost my husband to AIDS in September 2005. I am still grieving for what I have lost—loss of my spouse, loss of a friend, loss of a partner on this road with HIV, and loss of life as I know it. This article let me know that there really is life after HIV when it comes to dating. I don’t know if I am ready to find someone else, but at least I know that when I am ready, I have the courage to try.

Name withheld, via the Internet

Back to Top


Switching Medications

Dear Dr. Berger: Because of extremely uncomfortable side effects from the medications I was taking (Kaletra, Epivir, and Zerit), I have asked my doctor to change my medications (to Truvada and the new formulation of Kaletra). I am hoping that I will get some relief from the diarrhea, sleeplessness, and tiredness. Am I doing the right thing? My T-cells are around 200 and my viral load is undetectable with the ultrasensitive test. I have also heard of HIV-positive people living med free. Do you lend any credence to that?

Daniel S. Berger, M.D., responds: Thanks for writing us. Your situation is not that uncommon and I agree with your comments. First of all, Zerit is a medication that we believe has long-term side effects that may be irreversible. These include neuropathy, that can manifest as numbness in the feet that often progress to pain; lipoatrophy, loss of fat from the face, buttocks, legs and arms, altering one’s appearance; and lastly, elevated cholesterol and other blood fats that increase the risk of heart disease. In my practice it is unusual for me to prescribe this medication. Truvada has been shown in clinical trials to be superior to other combination pills and appears to be a much more patient-friendly option, instead of your current Zerit plus Epivir regimen.

In regards to diarrhea, although Kaletra has a new formulation, there are also other new protease inhibitors that appear to cause much less diarrhea than Kaletra. It is uncertain in my mind whether your diarrhea would improve with the new formulation of Kaletra, only that there will be less pills. Kaletra, by the way, can also elevate cholesterol and other blood fats, which taken together with Zerit, can be a cardiovascular risk combo. Other protease inhibitor options that are patient friendly include Lexiva, Reyataz, and TMC-114 (which is on expanded access and expected to be approved in June). These can all be discussed with your physician. If your physician is uncomfortable with making changes, he and you may consider seeking advice and guidance or suggestions from an HIV specialist.

Back to Top


 
 
Main Positively Aware Page:
  Positively Aware
 
 

This site contains HIV prevention messages that may not be appropriate for all audiences. Since HIV infection is spread primarily through sexual practices or by sharing needles, prevention messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this website.

Este sitio del web contiene mensajes de la prevención del VIH que pueden no ser appropiados para todas las audiencias. Puesto que la infección del VIH es propagada sobre todo con prácticas sexuales o por compartiendo jeringas, los mensajes y los programas de la prevención pueden dirigirse a estos asuntos. Si usted no está buscando tal información o puede ser ofendido por tales materiales, salga por favor de este website.

 
 

Opinions expressed in Positively Aware, Positively Aware en Español, or tpan.com are not necessarily those of staff or membership of Test Positive Aware Network (TPAN), its supporters and sponsors, or distributing agencies. Information, resources, and advertising in Positively Aware, Positively Aware en Español, or tpan.com do not constitute endorsement or recommendation of any medical treatment or product.

TPAN recommends that all medical treatments or products be discussed thoroughly and frankly with a licensed and fully HIV-informed medical practitioner, preferably a personal physician.

Although Positively Aware, Positively Aware en Español, and tpan.com take great care to ensure the accuracy of all the information that it presents, Positively Aware, Positively Aware en Español, and tpan.com staff and volunteers, TPAN, or the institutions and personnel who provide us with information cannot be held responsible for any damages, direct or consequential, that arise from use of this material or due to errors contained herein.

 
 
Home   | About TPAN   | Publications   | Client Services   | Events   | Online Directory   | Resources   | Contact Us